| Name | Title | Contact Details |
|---|
Unlike traditional approaches that only address symptoms, Cardionomic addresses the conditions root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality. This breakthrough therapy is also expected to increase pharmacological tolerance at discharge, which will reduce costly readmission and extend life. Spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, Cardionomic is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.
Innomed is a Savannah, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Spotlight Innovation, Inc., provides solutions for healthcare-focused companies commercializing healthcare intellectual property developed by major centers of academia in the United States. The Company focuses on identifying, validating and acquiring/cooperating with early stage companies developing healthcare technologies including pharmaceuticals, devices and equipment, diagnostic products and healthcare IT.
Lincoln Health is a healthcare organization affiliated with the Huntsville Hospital Health System.
Levin Group is a Owings Mills, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.